Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY: NVO )

87.37 -1.34 (-1.51%)
Official Closing Price Updated: 1:10 PM EST, Dec 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novo Nordisk A/S Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
68 69 Next >
VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday?
It’s another risk-off day on Wall Street, with all major U.S. indices trading in the red. The CBOE Volatility Index (VIX), often referred to as the market’s fear gauge, spiked over 10%, reaching levels... 
Via Benzinga
Topics Stocks
Exposures US Equities
AI Demand and New Deals Make Ginkgo Bioworks Stock a Speculative Buy
Ginkgo Bioworks has multiple, positive catalysts that can make the low valuation of Ginkgo Bioworks stock melt up. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Forget Boring Diversification! 3 Wild-Card Stocks to Spice Up Your Portfolio
These three wild-card stocks will spice up your portfolio in ways boring diversification never could, so read on. 
Via InvestorPlace
$1000 Invested In Novo Nordisk 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Novo Nordisk Faces Setback in Netherlands Over Wegovy Insurance Coverage
Novo Nordisk expresses disappointment over the Dutch Health Care Institute's advice against including Wegovy in the Netherlands' basic insurance, citing unclear health benefits and high costs. 
Via Benzinga
Why Roche Stock Just Popped, but Eli Lilly and Novo Nordisk Dropped
Roche has a new GLP-1 weight loss drug in the works -- and one very cheap stock. 
Via The Motley Fool
Pfizer And Roche Advance On Their Weight Loss Drug Journeys
After previously discounting a twice-daily version of its weight loss drug due to patients having difficulties tolerating it, Pfizer Inc (NYSE: PFE) moved forward with the once-daily version. On... 
Via Benzinga
Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?
Eli Lilly, Novo Nordisk, Viking Therapeutics, and Structure Therapeutics shares are down following Roche's promising CT-996 trial results for type 2 diabetes and obesity. Get insights into the latest... 
Via Benzinga
Eli Lilly, Novo Nordisk Fall As Roche Releases Weight-Loss Drug Data
Roche released early-stage data on its oral weight-loss drug. 
Via Investor's Business Daily
3 Hot Growth Stocks That Will Make You Forget About AMD
There are a number of hot growth stocks out there that can outdo AMD, even after its latest acquisition of Silo AI. 
Via InvestorPlace
Senate To Review Novo Nordisk's Levemir Insulin Discontinuation
Novo Nordisk will meet with U.S. Senate aides to discuss the discontinuation of Levemir, its long-acting insulin, amid concerns about manufacturing constraints and patient access. Senators press for... 
Via Benzinga
3 Dow Jones Stocks to Buy at 52-Week Lows in July
The Dow Jones has rallied, similar to the other well-known market indices, but not all of its stocks are trading at all-time highs. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
This Analyst Sees Potential Downside In Eli Lilly, Adjusts Model For Acquired IPR&D Charges
Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating on Eli Lilly with a price target of $885. Eli Lilly's Q2 FY24 earnings report on August 8 will include a pre-tax IPR&D charge of... 
Via Benzinga
7 Top-Quality Stocks to Buy Now: July 2024
With plenty of uncertainties ahead, investors should look for top-quality stocks for the remainder of the year. 
Via InvestorPlace
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
Revenue is climbing at these two drug companies -- and the trend should continue. 
Via The Motley Fool
2 Incredibly Cheap Growth Stocks to Buy Now
Price is just one factor to consider. 
Via The Motley Fool
Is Eli Lilly a Good Dividend Stock to Buy Now?
A leading anti-obesity treatment plus a new Alzheimer's drug could drive profits through the roof. 
Via The Motley Fool
This 1 Piece of Bad News for Novo Nordisk Is Good News for Eli Lilly Stock
A new study raises important implications regarding the competitive balance between these two companies. 
Via The Motley Fool
Here's 80 Billion More Reasons to Buy Novo Nordisk Stock
Hopes are high about one of its next-gen candidates. 
Via The Motley Fool
The 7 Most Important Stocks to Watch as Q2 Earnings Season Kicks Off
Seven Q2 earnings season stocks are powered by catalysts that could have a major impact on their companies fortunes. 
Via InvestorPlace
Did Eli Lilly Just Get a Leg Up on Novo Nordisk?
Eli Lilly's latest milestone sets it apart from its rival Novo Nordisk. 
Via The Motley Fool
The Weight Loss Market Can Surge To $400B By 2032, And These Stocks Will Rule It
Despite Novo Nordisk's momentum, Eli Lilly seems a better long-term bet. Pfizer could surprise everyone from an undervalued position. 
Via Talk Markets
Novo Nordisk Stock Pops After Weight-Loss Drug Cuts Dementia Risk In Yearlong Study
A yearlong study at the University of Oxford suggests GLP-1 drugs could play a role in protecting brain health. 
Via Investor's Business Daily
Stock Market Shifts Toward Small Caps After Tame CPI; JPMorgan, Taiwan Semi, Tesla In Focus: Weekly Review
Megacaps and chip plays tumbled Thursday, but mostly still have healthy charts. 
Via Investor's Business Daily
Using Ozempic, Zepbound Or Other Weight Loss Drugs? Inform Doctors Before Anesthesia Or Surgery, European Medicines Agency Issues Advisory
EMA advises patients on GLP-1 weight-loss drugs like Wegovy to inform their doctors before surgery due to potential respiratory risks. New warnings to be included in product information to ensure... 
Via Benzinga
3 Global Stocks Worth Buying as America Stumbles
It never hurts to diversify your portfolio by adding global stocks, even if America doesn’t fall into the abyss. 
Via InvestorPlace
The 3 Most Undervalued Pharma Stocks to Buy in July 2024
Pharma stocks can be great investments during times of growth and recession, and are made even better if the stock is undervalued. 
Via InvestorPlace
Topics Economy
Exposures Economy
Novo Nordisk's 'Miracle' Weight Loss Drug Ozempic Linked To 48% Lower Risk Of Dementia, Study Finds
Novo Nordisk has found that its diabetes drug, Ozempic, is linked to a significant reduction in the risk of dementia and other cognitive issues. 
Via Benzinga
Eli Lilly, Novo Nordisk Shares Dip As Pfizer Ramps Up Diabetes Drug Competition
Shares of Eli Lilly and Co (NYSE: LLY) and Novo Nordisk A/S (NYSE: NVO) are facing declines Thursday, maybe influenced by competitive developments and regulatory updates in the pharmaceutical sector. 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
68 69 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.